InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Apel Daniel Joseph, Chief Financial Officer. Insider active across 1 company, notably Arrowhead Pharmaceuticals, INC.. In total, 2 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €384k. Activity tracked since 22 April 2026. The latest transaction was disclosed on 22 April 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
3,208 shares@ US$70.110.0017% mcap50.0% of flowCommon StockSEC:0000879407-26-000039
3,208 shares@ US$70.110.0018% mcap50.0% of flowCommon StockSEC:0000879407-26-000039:0
2 of 2 declarations
About Apel Daniel Joseph
Daniel Joseph Apel is the Chief Financial Officer of ARROWHEAD PHARMACEUTICALS, INC. He oversees financial operations and contributes to the overall strategy of the company.
